Crosstalk between lysine-specific demethylase 1 (LSD1) and histone deacetylases mediates antineoplastic efficacy of HDAC inhibitors in human breast cancer cells

Carcinogenesis

Volumn 34, Issue 6, 2013, Pages 1196-1207

  Vasilatos, Shauna N ^a   Katz, Tiffany A ^a   Oesterreich, Steffi ^a,b   Wan, Yong ^a,b   Davidson, Nancy E ^a,b   Huang, Yi ^a,b  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1C; HISTONE DEACETYLASE; HISTONE DEACETYLASE 5; HISTONE DEACETYLASE INHIBITOR; HISTONE DEMETHYLASE; HISTONE DEMETHYLASE LSD1; HISTONE H3; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; NUCLEAR RECEPTOR NUR77; PARGYLINE; RGS PROTEIN; RGS PROTEIN 16; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; UVOMORULIN; VORINOSTAT;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BIK TUMOR SUPPRESSOR GENE; BREAST CELL; CANCER CELL; CANCER INHIBITION; CONTROLLED STUDY; CYTOTOXICITY; DOWN REGULATION; DRUG ANTAGONISM; DRUG POTENTIATION; ENZYME INHIBITION; GENE EXPRESSION; GENE SILENCING; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; MOLECULAR INTERACTION; NR4A1 TUMOR SUPPRESSOR GENE; PCDH1 TUMOR SUPPRESSOR GENE; PRIORITY JOURNAL; RGS16 TUMOR SUPPRESSOR GENE; RNA INTERFERENCE; TRIPLE NEGATIVE BREAST CANCER; TUMOR SUPPRESSOR GENE; WESTERN BLOTTING;

APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BREAST NEOPLASMS; CADHERINS; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; GENES, TUMOR SUPPRESSOR; HISTONE DEACETYLASE INHIBITORS; HISTONE DEACETYLASES; HISTONE DEMETHYLASES; HISTONES; HUMANS; HYDROXAMIC ACIDS; MEMBRANE PROTEINS; METHYLATION; MONOAMINE OXIDASE INHIBITORS; NF-KAPPA B; NUCLEAR RECEPTOR SUBFAMILY 4, GROUP A, MEMBER 1; PARGYLINE; RGS PROTEINS; RNA INTERFERENCE; RNA, SMALL INTERFERING;

EID: 84878964098     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgt033     Document Type: Article

References (43)

1. Ficner,R. (2009) Novel structural insights into class I and II histone deacetylases. Curr. Top. Med. Chem., 9, 235-240.
2. Marks,P.A. et al. (2009) Histone deacetylase inhibitors: potential in cancer therapy. J. Cell. Biochem., 107, 600-608.
3. Sharma,D. et al. (2006) Restoration of tamoxifen sensitivity in estrogen receptor-negative breast cancer cells: tamoxifen-bound reactivated ER recruits distinctive corepressor complexes. Cancer Res., 66, 6370-6378.
4. Pruitt,K. et al. (2006) Inhibition of SIRT1 reactivates silenced cancer genes without loss of promoter DNA hypermethylation. PLoS Genet., 2, e40.
5. Traynor,A.M. et al. (2009) Vorinostat (NSC# 701852) in patients with relapsed non-small cell lung cancer: a Wisconsin Oncology Network phase II study. J. Thorac. Oncol., 4, 522-526.
6. Luu,T.H. et al. (2008) A phase II trial of vorinostat (suberoylanilide hydroxamic acid) in metastatic breast cancer: a California Cancer Consortium study. Clin. Cancer Res., 14, 7138-7142.
7. Modesitt,S.C. et al. (2008) A phase II study of vorinostat in the treatment of persistent or recurrent epithelial ovarian or primary peritoneal carcinoma: a Gynecologic Oncology Group study. Gynecol. Oncol., 109, 182-186.
8. Blumenschein,G.R. Jr et al. (2008) Phase II trial of the histone deacetylase inhibitor vorinostat (Zolinza, suberoylanilide hydroxamic acid, SAHA) in patients with recurrent and/or metastatic head and neck cancer. Invest. New Drugs, 26, 81-87.
9. Belinsky,S.A. et al. (2003) Inhibition of DNA methylation and histone deacetylation prevents murine lung cancer. Cancer Res., 63, 7089-7093.
10. Lee,M.J. et al. (2008) Histone deacetylase inhibitors in cancer therapy. Curr. Opin. Oncol., 20, 639-649.
11. Rasheed,W.K. et al. (2007) Histone deacetylase inhibitors in cancer therapy. Expert Opin. Investig. Drugs, 16, 659-678.
12. Huang,Y. et al. (2007) Inhibition of lysine-specific demethylase 1 by polyamine analogues results in reexpression of aberrantly silenced genes. Proc. Natl Acad. Sci. USA, 104, 8023-8028.
13. Huang,Y. et al. (2009) Novel oligoamine analogues inhibit lysine-specific demethylase 1 and induce reexpression of epigenetically silenced genes. Clin. Cancer Res., 15, 7217-7228.
14. Huang,Y. et al. (2012) Inhibitors of histone demethylation and histone deacetylation cooperate in regulating gene expression and inhibiting growth in human breast cancer cells. Breast Cancer Res. Treat., 131, 777-789.
15. Huang,Y. et al. (2009) Polyamine analogues targeting epigenetic gene regulation. Essays Biochem., 46, 95-110.
16. Shi,Y. et al. (2004) Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. Cell, 119, 941-953.
17. Lee,M.G. et al. (2005) An essential role for CoREST in nucleosomal histone 3 lysine 4 demethylation. Nature, 437, 432-435.
18. Garcia-Bassets,I. et al. (2007) Histone methylation-dependent mechanisms impose ligand dependency for gene activation by nuclear receptors. Cell, 128, 505-518.
19. Lim,S. et al. (2010) Lysine-specific demethylase 1 (LSD1) is highly expressed in ER-negative breast cancers and a biomarker predicting aggressive biology. Carcinogenesis, 31, 512-520.
20. Metzger,E. et al. (2005) LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription. Nature, 437, 436-439.
21. Abukhdeir,A.M. et al. (2006) Physiologic estrogen receptor alpha signaling in non-tumorigenic human mammary epithelial cells. Breast Cancer Res. Treat., 99, 23-33.
22. Huang,Y. et al. (2003) A novel polyamine analog inhibits growth and induces apoptosis in human breast cancer cells. Clin. Cancer Res., 9, 2769-2777.
23. Chou,T.C. et al. (1984) Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv. Enzyme Regul., 22, 27-55.
24. Tusher,V.G. et al. (2001) Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl Acad. Sci. USA, 98, 5116-5121.
25. Alexopoulou,A.N. et al. (2010) Dissecting the transcriptional networks underlying breast cancer: NR4A1 reduces the migration of normal and breast cancer cell lines. Breast Cancer Res., 12, R51.
26. Novak,P. et al. (2008) Agglomerative epigenetic aberrations are a common event in human breast cancer. Cancer Res., 68, 8616-8625.
27. Liang,G. et al. (2009) RGS16 inhibits breast cancer cell growth by mitigating phosphatidylinositol 3-kinase signaling. J. Biol. Chem., 284, 21719-21727.
28. Neve,R.M. et al. (2006) A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell, 10, 515-527.
29. Zhou,Q. et al. (2007) Histone deacetylase inhibitor LBH589 reactivates silenced estrogen receptor alpha (ER) gene expression without loss of DNA hypermethylation. Cancer Biol. Ther., 6, 64-69.
30. Jones,P.A. et al. (2007) The epigenomics of cancer. Cell, 128, 683-692.
31. Huang,Y. et al. (2011) Epigenetics in breast cancer: what's new? Breast Cancer Res., 13, 225.
32. Wu,Q. et al. (1997) Inhibition of trans-retinoic acid-resistant human breast cancer cell growth by retinoid X receptor-selective retinoids. Mol. Cell. Biol., 17, 6598-6608.
33. Moll,U.M. et al. (2006) p53 and Nur77/TR3 - transcription factors that directly target mitochondria for cell death induction. Oncogene, 25, 4725-4743.
34. Druey,K.M. et al. (1996) Inhibition of G-protein-mediated MAP kinase activation by a new mammalian gene family. Nature, 379, 742-746.
35. De Vries,L. et al. (1999) RGS proteins: more than just GAPs for heterotrimeric G proteins. Trends Cell Biol., 9, 138-144.
36. Sun,G. et al. (2010) Histone demethylase LSD1 regulates neural stem cell proliferation. Mol. Cell. Biol., 30, 1997-2005.
37. Wiechec,E. et al. (2008) A fragile site within the HPC1 region at 1q25.3 affecting RGS16, RGSL1, and RGSL2 in human breast carcinomas. Genes. Chromosomes Cancer, 47, 766-780.
38. Ozes,O.N. et al. (1999) NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase. Nature, 401, 82-85.
39. deGraffenried,L.A. et al. (2004) NF-kappa B inhibition markedly enhances sensitivity of resistant breast cancer tumor cells to tamoxifen. Ann. Oncol., 15, 885-890.
40. Gong,L. et al. (2003) Inactivation of NF-kappaB by genistein is mediated via Akt signaling pathway in breast cancer cells. Oncogene, 22, 4702-4709.
41. Yoon,K. et al. (2011) Activation of nuclear TR3 (NR4A1) by a diindolylmethane analog induces apoptosis and proapoptotic genes in pancreatic cancer cells and tumors. Carcinogenesis, 32, 836-842.
42. Mohan,H.M. et al. (2012) Molecular pathways: the role of NR4A orphan nuclear receptors in cancer. Clin. Cancer Res., 18, 3223-3228.
43. Budhu,A.S. et al. (2002) Direct channeling of retinoic acid between cellular retinoic acid-binding protein II and retinoic acid receptor sensitizes mammary carcinoma cells to retinoic acid-induced growth arrest. Mol. Cell. Biol., 22, 2632-2641.